Actively Recruiting
Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)
Led by Institut Claudius Regaud · Updated on 2025-05-20
33
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a new way to care for patients with solid cancers or blood cancers who receive oral chemotherapy. This open-label, single-center study aims to test if it is possible to manage treatment in a more decentralized way. Instead of patients visiting the hospital pharmacy monthly without medical consultation, this study explores coordinating care through an Advanced Practice Nurse (APN) who oversees treatment delivery at patients' homes. The study involves organizing two home visits by a service-providing nurse for each patient, coordinated by the APN at the investigation center. During these visits, the APN will check the patient's vital signs and hand over the oral chemotherapy treatment. On the second visit, patients will also complete a satisfaction questionnaire. This approach replaces some hospital visits with home-based care, aiming to improve treatment management and monitoring. Participants will be followed for seven months, during which researchers will assess how feasible the decentralized care pathway is. They will monitor patient adherence, satisfaction, and the efficiency of data collection between home and hospital, including integration with electronic patient records. The study also evaluates the operation of the computerized patient record tool used in this process. This comprehensive monitoring helps ensure safety and gathers important information about this new care approach.
CONDITIONS
Brief Title
Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years old
- Diagnosed with solid cancer or haematological malignancy and receiving oral retroceded therapy as part of standard care
- Performance status (ECOG) of 0 to 2
- Contactable by telephone for follow-up by the Advanced Practice Nurse
- Willing to have two home visits within 6 months of inclusion
You will not qualify if you...
- Pregnant or breastfeeding
- Psychological, family, geographical, or social conditions that may prevent consent or compliance as judged by the oncologist
- Deprived of liberty by administrative or legal decision, or under guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 7 months
Participants receive two home visits by a nurse coordinated by the Advanced Practice Nurse. During these visits, vital signs are taken and treatment is handed over. The second visit includes completion of a satisfaction questionnaire.
2 home visits
Trial Site Locations
Total: 1 location
1
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France, 31059
Actively Recruiting
Research Team
P
Pierre BORIES
A
Alexandra LAMBERT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here